Cellular and Molecular Mechanisms of Drug Dependence
The DOI matches its Crossref record; 188 of the 189 references it cites were found in a registry or an index.
Abstract
The molecular and cellular actions of three classes of abused drugs—opiates, psychostimulants, and ethanol—are reviewed in the context of behavioral studies of drug dependence. The immediate effects of drugs are compared to those observed after long-term exposure. A neurobiological basis for drug dependence is proposed from the linkage between the cellular and behavioral effects of these drugs.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The emotional dysregulation that is associated with the withdrawal/negative affect stage also involves a between-system neuroadaptation, in which neuro-chemical systems other than those involved in the positive rewarding effects of drugs of abuse are recruited or dysregulated by chronic activation of the reward system.”
From Neurobiology of addiction: a neurocircuitry analysis (2016) · cites this paper as [68]
In the citing paper
“A key theory that was proposed was called opponent process theory (Solomon andCorbit, 1973, 1974;D'Amato, 1974;Hoffman and Solomon, 1974;Solomon, 1980;Koob and Bloom, 1988).”
From Drug Addiction: Hyperkatifeia/Negative Reinforcement as a Framework for Medications Development (2021) · cites this paper as Koob and Bloom, 1988
In the citing paper
“A conceptual framework that was adopted to explain the neural systems that mediate the long-hypothesized opponent process adaptation to excessive reward system engagement and drive negative reinforcement involved the within-system downregulation of brain reward circuitry and the between-system recruitment of brain stress circuitry (Koob and Bloom, 1988).”
From Drug Addiction: Hyperkatifeia/Negative Reinforcement as a Framework for Medications Development (2021) · cites this paper as Koob and Bloom, 1988
In the citing paper
“Subsequently, the focus of between-system neuroadaptations fell on understanding neurocircuitry within the extended amygdala and its role in opponent process, more specifically hyperkatifeia (Koob and Bloom, 1988;Koob and Le Moal, 2008;Koob, 2019).”
From Drug Addiction: Hyperkatifeia/Negative Reinforcement as a Framework for Medications Development (2021) · cites this paper as Koob and Bloom, 1988
In the citing paper
“In addition to the above within-system neuroadaptations, other neurocircuits appear to be activated by excessive drug intake that act in hedonic opposition to reward neurotransmitter circuits [corticotropinreleasing factor (CRF), norepinephrine, glucocorticoids, dynorphin, hypocretin, and neuroimmune factors] or act to protect against the development of hyperkatifeia (NPY, nociceptin, endocannabin”
From Drug Addiction: Hyperkatifeia/Negative Reinforcement as a Framework for Medications Development (2021) · cites this paper as Koob and Bloom, 1988
4 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Diagnostic and Statistical Manual of Mental Disorders
Siegel, L. J., & Fletcher‐Janzem, E. (2008) · Encyclopedia of Special Education · doi:10.1002/9780470373699.speced0655 · Cited by 8,477
Identification of two related pentapeptides from the brain with potent opiate agonist activity
Hughes, J., Smith, T. W., Kosterlitz, H. W., Fothergill, L. A., Morgan, B. A., & Morris, H. R. (1975) · Nature · doi:10.1038/258577a0 · Cited by 3,806
Positron emission tomographic studies of the cortical anatomy of single-word processing
Petersen, S. E., Fox, P. T., Posner, M. I., Mintun, M., & Raichle, M. E. (1988) · Nature · doi:10.1038/331585a0 · Cited by 2,593
Neurogenetic Adaptive Mechanisms in Alcoholism
Cloninger, C. R. (1987) · Science · doi:10.1126/science.2882604 · Cited by 2,234
Cocaine Receptors on Dopamine Transporters Are Related to Self-Administration of Cocaine
Ritz, M. C., Lamb, R. J., Goldberg, S. R., & Kuhar, M. J. (1987) · Science · doi:10.1126/science.2820058 · Cited by 2,180
Aston-Jones, G., & Bloom, F. (1981) · The Journal of Neuroscience · doi:10.1523/jneurosci.01-08-00876.1981 · Cited by 1,960
Self-citationNucleus locus ceruleus: new evidence of anatomical and physiological specificity
Foote, S. L., Bloom, F. E., & Aston-Jones, G. (1983) · Physiological Reviews · doi:10.1152/physrev.1983.63.3.844 · Cited by 1,901
Self-citationLocalization of Cognitive Operations in the Human Brain
Posner, M. I., Petersen, S. E., Fox, P. T., & Raichle, M. E. (1988) · Science · doi:10.1126/science.3289116 · Cited by 1,429
Abstinence Symptomatology and Psychiatric Diagnosis in Cocaine Abusers: Clinical Observations
Gawin, F. H. (1986) · Archives of General Psychiatry · doi:10.1001/archpsyc.1986.01800020013003 · Cited by 1,151
Aston-Jones, G., & Bloom, F. (1981) · The Journal of Neuroscience · doi:10.1523/jneurosci.01-08-00887.1981 · Cited by 1,068
Self-citation
Research works printed but not linked: 46
- AMERICAN JOURNAL OF PSYCHIATRY 142 7: 9 (1985).
- AMIT, Z, ARCHIVES INTERNATIONALES DE PHARMACODYNAMIE ET DE THERAPIE 23: 65 (1977).
- BAXTER, L. R., JOURNAL OF CLINICAL PSYCHIATRY 49: 23 (1988).
- Bjorklund, A., Handbook of Chemical Neuroanatomy 2: 55 (1984).
- Bloom, F. E., Catecholamines, Neuropharmacology, and Central Nervous System: 159 (1984).
- BRITTON, K.T., REGUL PEPT 16: 315 (1987).
- DACKIS, C.A., BROMOCRIPTINE AS TREATMENT OF COCAINE ABUSE, LANCET 1: 1151 (1985).
- DUGGAN, A. W., PHARMACOLOGICAL REVIEWS 35: 219 (1982).
- EDDY, N.B., BULLETIN OF THE WORLD HEALTH ORGANIZATION 32: 723 (1965).
- FREDERICKSON, RCA, LIFE SCI 24: 541 (1975).
- GRIFFITHS, R.R., ADV SUBSTANC ABUSE 1: 1 (1980).
- HARDING, W.M., ADV SUBSTANC ABUSE 3: 27 (1983).
- HENRIKSEN, S.J., NATL I DRUG ABUSE RE 84: 239 (1984).
- HIMMELSBACH, C.K., FEDERATION PROCEEDINGS 2: 201 (1943).
- HUBNER, C.B., SOCIETY FOR NEUROSCIENCE. ABSTRACTS 13: 1717 (1987).
- JAFFE, J.H., GOODMAN GILMANS PHAR: 532 (1985).
- JAFFE, J.H., RESEARCH PUBLICATIONS. ASSOCIATION FOR RESEARCH IN NERVOUS AND MENTAL DISEASE 46: 226 (1968).
- Khachaturian, H., Handbook of Chemical Neuroanatomy 4: 216 (1985).
- KOOB, G.F., SOCIETY FOR NEUROSCIENCE. ABSTRACTS 13: 918 (1987).
- KORNETSKY, C, AN ANIMAL-MODEL FOR OPIATE INDUCED EUPHORIA AND ANALGESIA, THERAPEUTISCHE UMSCHAU 39: 617 (1982).
- KRITIKOS, P.G., UN B NARC 19: 187 (1967).
- Kuhar, M. H., Nature 245:447 (1976).
- LACEY, M.G., INT NARCOTICS RES C: 85 (1988).
- LESLIE, F.M., PHARMACOL REV 39: 198 (1987).
- LI, T.K., NIDA RES MONOGR 66: 41 (1986).
- MADAMBA, S, SOCIETY FOR NEUROSCIENCE. ABSTRACTS 13: 501 (1987).
- Markou A. Soc. Neurosci. Abstr. in press.
- MARTIN, W.R., HDB EXPT PHARMACOLOG 45: 43 (1977).
- MARTIN, W.R., PHARMACOL REV 35: 283 (1984).
- MARTIN, W.R., PHARMACOL REV 35: 285 (1984).
- Merchenthaler, I., Handbook of Chemical Neuroanatomy 3: 273 (1985).
- MURPHY, J.M., ALCOHOL DRUG RES 7: 33 (1986).
- NADEL, L, ESSAYS NERVOUS SYSTE: 367 (1974).
- OBRIEN, C.P., ANN NY ACAD SCI 398: 377 (1983).
- OBRIEN, C.P., PHARMACOL REV 27: 533 (1976).
- PICKENS, R, HDB PSYCHOPHARMACOLO 12: 1 (1978).
- SAMSON, H.H., NEUROBEHAVIORAL PHAR: 221 (1987).
- SHUSTER, L, NIDA RES MONOGR 54: 50 (1984).
- TABAKOFF, B, ANIMAL MODELS ALCOHO: 271 (1980).
- VACCARINO, F.J., EFFECTS OF INTRACEREBROVENTRICULAR ADMINISTRATION OF METHYL NALOXONIUM CHLORIDE ON HEROIN SELF-ADMINISTRATION IN THE RAT, PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR 23: 495 (1985).
- WALMSLEY, J, PHARMACOL REV 35: 69 (1983).
- WAY, E.L., ANN NY ACAD SCI 398: 12 (1983).
- WHITE, F.J., NEUROPHARMACOLOGY DO: 67 (1987).
- WIKLER, A, NARCOTICS: 85 (1965).
- WILSON, JVR, BEHAV GENET 11: 291 (1984).
- WOODS, J.H., RECENT ADV STUDIES A: 413 (1970).
Cited by
Items 201–300 of 1,010
Winstanley, C. A., Dalley, J. W., Theobald, D. E. H., & Robbins, T. W. (2003) · Psychopharmacology · doi:10.1007/s00213-003-1546-3 · Cited by 256
Rassnick, S., Pulvirenti, L., & Koob, G. F. (1992) · Psychopharmacology · doi:10.1007/bf02245485 · Cited by 256
Self-citationCorticotropin releasing factor: A key role in the neurobiology of addiction
Zorrilla, E. P., Logrip, M. L., & Koob, G. F. (2014) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2014.01.001 · Cited by 254
Self-citationAhmed, S. H., & Koob, G. F. (2005) · Psychopharmacology · doi:10.1007/s00213-005-2180-z · Cited by 254
Self-citationArroyo, M., Markou, A., Robbins, T. W., & Everitt, B. J. (1998) · Psychopharmacology · doi:10.1007/s002130050774 · Cited by 252
PET evaluation of the dopamine system of the human brain.
Volkow, N. D., Fowler, J., Sj, G., Logan, J., Wang, G., Ding, Y., & Dewey, S. L. (1996) · PubMed · Cited by 299
The role of the brain reward system in depression
Naranjo, C. A., Tremblay, L. K., & Busto, U. E. (2001) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/s0278-5846(01)00156-7 · Cited by 245
Attention-deficit-hyperactivity disorder and reward deficiency syndrome
Oscar Berman, M., Blum, K., Chen, T. J., Braverman, E., Waite, R., Downs, W., Arcuri, V., Notaro, A., Palomo, T., & Comings (2008) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s2627 · Cited by 248
“(4) An alternate pathway involves norepinephrine in the locus ceruleus whose fi bers project into the hippocampus at a reward area centering around cluster cells, which have not been precisely identifi ed (designated as CAx).”
BackgroundDynamics of Neuronal Circuits in Addiction: Reward, Antireward, and Emotional Memory
Koob, G. F. (2009) · Pharmacopsychiatry · doi:10.1055/s-0029-1216356 · Cited by 245
Self-citationCicero, T. J., Adams, E. H., Geller, A., Inciardi, J. A., Muñoz, A., Schnoll, S. H., Senay, E. C., & Woody, G. E. (1999) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(99)00041-1 · Cited by 243
Kiyatkin, E. A., & Rebec, G. V. (1996) · Journal of Neurophysiology · doi:10.1152/jn.1996.75.1.142 · Cited by 243
Nirenberg, M. J., Chan, J., Pohorille, A., Vaughan, R. A., Uhl, G. R., Kuhar, M. J., & Pickel, V. M. (1997) · The Journal of Neuroscience · doi:10.1523/jneurosci.17-18-06899.1997 · Cited by 242
Jatlow, P., Elsworth, J. D., Bradberry, C. W., Winger, G., Taylor, J. R., Russell, R., & Roth, R. H. (1991) · Life Sciences · doi:10.1016/0024-3205(91)90217-y · Cited by 238
Nestler, E. J., Terwilliger, R. Z., Walker, J. R., Sevarino, K. A., & Duman, R. S. (1990) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1990.tb04602.x · Cited by 232
Meredith, G. E., Agolia, R., Arts, M. P. M., Groenewegen, H. J., & Zahm, D. S. (1992) · Neuroscience · doi:10.1016/0306-4522(92)90389-j · Cited by 231
Stress, Corticotropin‐releasing Factor, and Drug Addiction
KOOB, G. F. (1999) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1999.tb07876.x · Cited by 231
Self-citationKahlig, K. M., & Galli, A. (2003) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2003.08.065 · Cited by 230
Nicotinic mechanisms involved in the dopamine activating and reinforcing properties of ethanol
Söderpalm, B., Ericson, M., Olausson, P., Blomqvist, O., & Engel, J. A. (2000) · Behavioural Brain Research · doi:10.1016/s0166-4328(00)00203-5 · Cited by 230
Volkow, N. D., Wang, G.-J., Telang, F., Fowler, J. S., Alexoff, D., Logan, J., Jayne, M., Wong, C., & Tomasi, D. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1411228111 · Cited by 230
Robinson, T. (1998) · Neuroscience & Biobehavioral Reviews · doi:10.1016/s0149-7634(97)00020-1 · Cited by 230
Dopamine receptorsâphysiological understanding to therapeutic intervention potential
Emilien, G. (1999) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(99)00029-7 · Cited by 228
Neurocircuitry of alcohol addiction
(2014) · Handbook of Clinical Neurology · doi:10.1016/b978-0-444-62619-6.00003-3 · Cited by 225
Self-citationCOLOMBO, G., AGABIO, R., FA, M., GUANO, L., LOCHE, A., REALI, R., & GESSA, G. L. (1998) · Alcohol and Alcoholism · doi:10.1093/oxfordjournals.alcalc.a008368 · Cited by 227
Shirayama, Y., & Chaki, S. (2006) · Current Neuropharmacology · doi:10.2174/157015906778520773 · Cited by 225
Remifentanil tolerance and hyperalgesia: short‐term gain, long‐term pain?
Yu, E. H. Y., Tran, D. H. D., Lam, S. W., & Irwin, M. G. (2016) · Anaesthesia · doi:10.1111/anae.13602 · Cited by 225
Chapter 1. Neurocircuitry of Addiction
Koob, G. F., & Volkow, N. D. (2021) · The American Psychiatric Association Publishing Textbook of Substance Use Disorder Treatment · doi:10.1176/appi.books.9781615373970.kb01 · Cited by 225
Self-citationAcquas, E., & Di Chiara, G. (1992) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1992.tb10033.x · Cited by 223
DAT isn’t all that: cocaine reward and reinforcement require Toll-like receptor 4 signaling
Northcutt, A. L., Hutchinson, M. R., Wang, X., Baratta, M. V., Hiranita, T., Cochran, T. A., Pomrenze, M. B., Galer, E. L., Kopajtic, T. A., Li, C. M., et al. (2015) · Molecular Psychiatry · doi:10.1038/mp.2014.177 · Cited by 221
Leshner, A. I., & Koob, G. F. (1999) · Proceedings of the Association of American Physicians · doi:10.1046/j.1525-1381.1999.09218.x · Cited by 217
Self-citationAssociation of the A1 allele of the D2 dopamine receptor gene with severe alcoholism
Blum, K., Noble, E. P., Sheridan, P. J., Finley, O., Montgomery, A., Ritchie, T., Ozkaragoz, T., Fitch, R. J., Sadlack, F., Sheffield, D., et al. (1991) · Alcohol · doi:10.1016/0741-8329(91)90693-q · Cited by 213
HOEBEL, B. G., HERNANDEZ, L., SCHWARTZ, D. H., MARK, G. P., & HUNTER, G. A. (1989) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1989.tb53242.x · Cited by 220
Brain glucose metabolism in chronic marijuana users at baseline and during marijuana intoxication
Volkow, N. D., Gillespie, H., Mullani, N., Tancredi, L., Grant, C., Valentine, A., & Hollister, L. (1996) · Psychiatry Research: Neuroimaging · doi:10.1016/0925-4927(96)02817-x · Cited by 219
Ikemoto, S., & Panksepp, J. (1996) · Behavioral Neuroscience · doi:10.1037//0735-7044.110.2.331 · Cited by 218
DNA Methylation Regulates Cocaine-Induced Behavioral Sensitization in Mice
Anier, K., Malinovskaja, K., Aonurm-Helm, A., Zharkovsky, A., & Kalda, A. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2010.128 · Cited by 213
Involvement of D2 dopamine receptors in the nucleus accumbens in the opiate withdrawal syndrome
Harris, G. C., & Aston-Jones, G. (1994) · Nature · doi:10.1038/371155a0 · Cited by 214
The reality of comorbidity: Depression and drug abuse
Volkow, N. D. (2004) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.07.007 · Cited by 213
Nicola, S., Kombian, S., & Malenka, R. (1996) · The Journal of Neuroscience · doi:10.1523/jneurosci.16-05-01591.1996 · Cited by 212
Beitner‐Johnson, D., & Nestler, E. J. (1991) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1991.tb02133.x · Cited by 212
Whole-Cell Plasticity in Cocaine Withdrawal: Reduced Sodium Currents in Nucleus Accumbens Neurons
Zhang, X.-F., Hu, X.-T., & White, F. J. (1998) · The Journal of Neuroscience · doi:10.1523/jneurosci.18-01-00488.1998 · Cited by 208
Simultaneous LTP of non-NMDA- and LTD of NMDA-receptor-mediated responses in the nucleus accumbens
Kombian, S. B., & Malenka, R. C. (1994) · Nature · doi:10.1038/368242a0 · Cited by 207
Richter, R. M., & Weiss, F. (1999) · Synapse · doi:10.1002/(sici)1098-2396(19990615)32:4%3c254::aid-syn2%3e3.0.co;2-h · Cited by 207
Deroche, V., Piazza, P. V., Casolini, P., Maccari, S., Le Moal, M., & Simon, H. (1992) · Brain Research · doi:10.1016/0006-8993(92)90205-n · Cited by 207
Kosten, T. A., Miserendino, M. J. D., & Kehoe, P. (2000) · Brain Research · doi:10.1016/s0006-8993(00)02595-6 · Cited by 205
Opiate tolerance and dependence: receptors, G-proteins, and antiopiates
Harrison, L. M., Kastin, A. J., & Zadina, J. E. (1998) · Peptides · doi:10.1016/s0196-9781(98)00126-0 · Cited by 204
Lin, J. S., Roussel, B., Akaoka, H., Fort, P., Debilly, G., & Jouvet, M. (1992) · Brain Research · doi:10.1016/0006-8993(92)91713-o · Cited by 203
Bechara, A., & van der Kooy, D. (1989) · The Journal of Neuroscience · doi:10.1523/jneurosci.09-10-03400.1989 · Cited by 203
Medications development to treat alcohol dependence: a vision for the next decade
Litten, R. Z., Egli, M., Heilig, M., Cui, C., Fertig, J. B., Ryan, M. L., Falk, D. E., Moss, H., Huebner, R., & Noronha, A. (2012) · Addiction Biology · doi:10.1111/j.1369-1600.2012.00454.x · Cited by 202
A risk and maintenance model for bulimia nervosa: From impulsive action to compulsive behavior.
Pearson, C. M., Wonderlich, S. A., & Smith, G. T. (2015) · Psychological Review · doi:10.1037/a0039268 · Cited by 202
Rodd-Henricks, Z. A., McKinzie, D. L., Crile, R. S., Murphy, J. M., & McBride, W. J. (2000) · Psychopharmacology · doi:10.1007/s002139900347 · Cited by 201
Russell, V., de Villiers, A., Sagvolden, T., Lamm, M., & Taljaard, J. (1995) · Brain Research · doi:10.1016/0006-8993(95)00135-d · Cited by 200
Justice, A. J. H., & de Wit, H. (1999) · Psychopharmacology · doi:10.1007/s002130051033 · Cited by 199
“Notably, the reinforcing e⁄ects of stimulant drugs, in particular, are believed to be mediated by dopamine (e.g., Randrup and Munkvad 1966; Banerjee and Lin 1973; Wise 1978; Koob and Bloom 1988; Seiden et al. 1993).”
BackgroundRouge-Pont, F., Marinelli, M., Le Moal, M., Simon, H., & Piazza, P. (1995) · The Journal of Neuroscience · doi:10.1523/jneurosci.15-11-07189.1995 · Cited by 198
Tanda, G., & Di Chiara, G. (1998) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.1998.00135.x · Cited by 197
Opponent Process Model and Psychostimulant Addiction
Koob, G. F., Caine, S. B., Parsons, L., Markou, A., & Weiss, F. (1997) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(96)00438-8 · Cited by 196
Self-citationOxytocin and addiction: a review
L. Kovács, G., Sarnyai, Z., & Szabó, G. (1998) · Psychoneuroendocrinology · doi:10.1016/s0306-4530(98)00064-x · Cited by 195
BECKER, J. B., MOLENDA, H., & HUMMER, D. L. (2001) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2001.tb03564.x · Cited by 192
Shaham, Y., & Stewart, J. (1996) · Psychopharmacology · doi:10.1007/bf02246022 · Cited by 194
Psychostimulant abuse and neuroinflammation: emerging evidence of their interconnection.
Clark, K. H., Wiley, C. A., & Bradberry, C. W. (2013) · Neurotoxicity Research · doi:10.1007/s12640-012-9334-7 · Cited by 194
Dopamine signaling in the nucleus accumbens of animals self-administering drugs of abuse
Willuhn, I., Wanat, M. J., Clark, J. J., & Phillips, P. E. M. (2010) · Current Topics in Behavioral Neurosciences · doi:10.1007/7854_2009_27 · Cited by 193
Rodd, Z. A., Melendez, R. I., Bell, R. L., Kuc, K. A., Zhang, Y., Murphy, J. M., & McBride, W. J. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.1319-03.2004 · Cited by 193
The Biology of pro-Thyrotropin-Releasing Hormone-Derived Peptides*
Nillni, E. A., & Sevarino, K. A. (1999) · Endocrine Reviews · doi:10.1210/edrv.20.5.0379 · Cited by 194
CRF system recruitment mediates dark side of compulsive eating
Cottone, P., Sabino, V., Roberto, M., Bajo, M., Pockros, L., Frihauf, J. B., Fekete, E. M., Steardo, L., Rice, K. C., Grigoriadis, D. E., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0908789106 · Cited by 192
“Such between-system neuroadaptations (19) also occur during the transition to dependence on all major drugs of abuse (7, 8).”
BackgroundSelf-citationDopamine and alcoholism: neurobiological basis of ethanol abuse
Tupala, E., & Tiihonen, J. (2004) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2004.06.022 · Cited by 191
Opiate agonists microinjected into the nucleus accumbens enhance sucrose drinking in rats
Zhang, M., & Kelley, A. E. (1997) · Psychopharmacology · doi:10.1007/s002130050355 · Cited by 191
Cocaine inhibits GABA release in the VTA through endogenous 5-HT
Cameron, D., & Williams, J. (1994) · The Journal of Neuroscience · doi:10.1523/jneurosci.14-11-06763.1994 · Cited by 188
Allostasis and addiction: role of the dopamine and corticotropin-releasing factor systems
George, O., Le Moal, M., & Koob, G. F. (2012) · Physiology & Behavior · doi:10.1016/j.physbeh.2011.11.004 · Cited by 184
Self-citationCynthia's Dilemma: Consenting to Heroin Prescription
Charland, L. C. (2002) · American Journal of Bioethics · doi:10.1162/152651602317533686 · Cited by 187
Ericson, M., Blomqvist, O., Engel, J. A., & Söderpalm, B. (1998) · European Journal of Pharmacology · doi:10.1016/s0014-2999(98)00602-5 · Cited by 187
Coller, J. K., & Hutchinson, M. R. (2012) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2012.01.008 · Cited by 186
Hill, S. Y., Shen, S., Lowers, L., & Locke, J. (2000) · Biological Psychiatry · doi:10.1016/s0006-3223(00)00841-6 · Cited by 185
Liu, J., Nickolenko, J., & Sharp, F. R. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.18.8537 · Cited by 185
Nicola, S. M., & Malenka, R. C. (1997) · The Journal of Neuroscience · doi:10.1523/jneurosci.17-15-05697.1997 · Cited by 185
Stimulant-induced psychosis, the dopamine theory of schizophrenia, and the habenula
Ellison, G. (1994) · Brain Research Reviews · doi:10.1016/0165-0173(94)90012-4 · Cited by 182
Restraint increases dopaminergic burst firing in awake rats
Anstrom, K. K., & Woodward, D. J. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300730 · Cited by 181
“The activity within the mesolimbic system, particularly within ventral tegmental area (VTA) dopamine neurons, has been hypothesized to be critical to motivation, reinforcement, and learning (Koob and Bloom, 1988; Wise, 1996).”
BackgroundOrexin/hypocretin role in reward: implications for opioid and other addictions
Baimel, C., Bartlett, S. E., Chiou, L., Lawrence, A. J., Muschamp, J. W., Patkar, O., Tung, L., & Borgland, S. L. (2015) · British Journal of Pharmacology · doi:10.1111/bph.12639 · Cited by 179
Tizabi, Y., Copeland, R. L., Louis, V. A., & Taylor, R. E. (2002) · Alcoholism: Clinical & Experimental Research · doi:10.1097/00000374-200203000-00014 · Cited by 181
Kosten, T. A., Miserendino, M. J. D., Haile, C. N., DeCaprio, J. L., Jatlow, P. I., & Nestler, E. J. (1997) · Brain Research · doi:10.1016/s0006-8993(97)01205-5 · Cited by 181
Pain Responses in Methadone-Maintained Opioid Abusers
Compton, P., Charuvastra, V. C., Kintaudi, K., & Ling, W. (2000) · Journal of Pain and Symptom Management · doi:10.1016/s0885-3924(00)00191-3 · Cited by 181
Hayward, M. D., Duman, R. S., & Nestler, E. J. (1990) · Brain Research · doi:10.1016/0006-8993(90)90872-9 · Cited by 181
Beitner-Johnson, D., Guitart, X., & Nestler, E. (1992) · The Journal of Neuroscience · doi:10.1523/jneurosci.12-06-02165.1992 · Cited by 180
Carelli, R., & Deadwyler, S. (1994) · The Journal of Neuroscience · doi:10.1523/jneurosci.14-12-07735.1994 · Cited by 180
Gongwer, M. A., Murphy, J. M., McBride, W. J., Lumeng, L., & Li, T.-K. (1989) · Alcohol · doi:10.1016/0741-8329(89)90089-x · Cited by 179
Repeated Cocaine Modifies the Mechanism by which Amphetamine Releases Dopamine
Pierce, R. C., & Kalivas, P. W. (1997) · The Journal of Neuroscience · doi:10.1523/jneurosci.17-09-03254.1997 · Cited by 179
Oviedo, A., Glowa, J., & Herkenham, M. (1993) · Brain Research · doi:10.1016/0006-8993(93)90220-h · Cited by 179
Tomie, A., Grimes, K. L., & Pohorecky, L. A. (2008) · Brain Research Reviews · doi:10.1016/j.brainresrev.2007.12.003 · Cited by 177
Experimental approach to individual vulnerability to psychostimulant addiction
Deminiere, J. M., Piazza, P. V., Le Moal, M., & Simon, H. (1989) · Neuroscience & Biobehavioral Reviews · doi:10.1016/s0149-7634(89)80023-5 · Cited by 177
Chang, J., Sawyer, S., Lee, R., & Woodward, D. (1994) · The Journal of Neuroscience · doi:10.1523/jneurosci.14-03-01224.1994 · Cited by 177
Zangen, A., Nakash, R., Overstreet, D., & Yadid, G. (2001) · Psychopharmacology · doi:10.1007/s002130100746 · Cited by 177
Baclofen Inhibits Heroin Self-Administration Behavior and Mesolimbic Dopamine Release
Xi, Z.-X., & Stein, E. A. (1999) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)35044-x · Cited by 177
Swanson, C. J., Heath, S., Stratford, T. R., & Kelley, A. E. (1997) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(97)00043-9 · Cited by 176
Long-term opioid therapy: Assessment of consequences and risks
Savage, S. R. (1996) · Journal of Pain and Symptom Management · doi:10.1016/0885-3924(95)00202-2 · Cited by 176
Convergence of Reinforcing and Anhedonic Cocaine Effects in the Ventral Pallidum
Creed, M., Ntamati, N. R., Chandra, R., Lobo, M. K., & Lüscher, C. (2016) · Neuron · doi:10.1016/j.neuron.2016.09.001 · Cited by 176
Nitric oxide inhibits [3H]dopamine uptake
Pogun, S., Baumann, M. H., & Kuhar, M. J. (1994) · Brain Research · doi:10.1016/0006-8993(94)91818-x · Cited by 176
The role of basal ganglia in the control of generalized absence seizures
Deransart, C., Vercueil, L., Marescaux, C., & Depaulis, A. (1998) · Epilepsy Research · doi:10.1016/s0920-1211(98)00053-9 · Cited by 176
Serotonin1BReceptor Stimulation Enhances Cocaine Reinforcement
Parsons, L. H., Weiss, F., & Koob, G. F. (1998) · The Journal of Neuroscience · doi:10.1523/jneurosci.18-23-10078.1998 · Cited by 174
Self-citationElucidation of the neurobiology of depression: insights from a novel genetic animal model
Yadid, G., Nakash, R., Deri, I., Tamar, G., Kinor, N., Gispan, I., & Zangen, A. (2000) · Progress in Neurobiology · doi:10.1016/s0301-0082(00)00018-6 · Cited by 173
Robertson, G. S., & Jian, M. (1995) · Neuroscience · doi:10.1016/0306-4522(94)00426-6 · Cited by 172
Gratton, A., & Wise, R. (1994) · The Journal of Neuroscience · doi:10.1523/jneurosci.14-07-04130.1994 · Cited by 172
Yoshimoto, K., McBride, W. J., Lumeng, L., & Li, T. ‐. (1992) · Alcoholism: Clinical and Experimental Research · doi:10.1111/j.1530-0277.1992.tb00678.x · Cited by 172
Kelley, A. E., & Delfs, J. M. (1991) · Psychopharmacology · doi:10.1007/bf02244202 · Cited by 168
Metadata
- Authors
- Koob, G. F., & Bloom, F. E.
- Affiliations
- Scripps Clinic (US)
- ORCID
- Koob, George F.
- Venue
- Science
- Published
- 1988-11-04
- Volume
- 242
- Issue
- 4879
- Pages
- 715-723
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2061161259
- Semantic Scholar
- f6c96457aa8e089ddd837d35937c60d29361c45f
- Cited by
- 2,070
- References
- 189
- Citations by year
- 2026: 9 · 2025: 16 · 2024: 15 · 2023: 19 · 2022: 24 · 2021: 25 · 2020: 30 · 2019: 40 · 2018: 32 · 2017: 24 · 2016: 35 · 2015: 39 · 2014: 47 · 2013: 51 · 2012: 56
- FWCI
- 4.51
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute on Alcohol Abuse and Alcoholism (AA-06420)
- National Institute on Drug Abuse (DA04043, DA04398)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
- Keywords
- drug addiction, opiates, psychostimulants, ethanol, neurobiology of addiction, drug effects on behavior, long-term drug exposure
- MeSH terms
- Ethanol, Animals, Behavior, Animal, Brain, Cocaine, Drug Tolerance, Humans, Opium, Reinforcement, Psychology, Neurotransmitter Agents, Substance-Related Disorders
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.